Narinder Singh occupies the position of Executive Vice President-Technical Operations at Aimmune Therapeutics, Inc.

In the past Mr. Singh was Senior VP-Pharmaceutical Sciences & Manufacturing at Genocea Biosciences, Inc. and VP-Drug Product Development & Manufacturing at Momenta Pharmaceuticals, Inc.

Narinder Singh received an undergraduate degree and a graduate degree from Indian Institute of Technology New Delhi, a graduate degree from the University of Houston and an MBA from UCLA Anderson School of Management.